Literature DB >> 24399423

Cardiac safety concerns remain for citalopram at dosages above 40 mg/day.

Steven T Bird, Victor Crentsil, Robert Temple, Simone Pinheiro, Dorothy Demczar, Marc Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24399423     DOI： 10.1176/appi.ajp.2013.13070905

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Real Patient and its Virtual Twin: Application of Quantitative Systems Toxicology Modelling in the Cardiac Safety Assessment of Citalopram.

Authors:  Nikunjkumar Patel; Barbara Wiśniowska; Masoud Jamei; Sebastian Polak
Journal:  AAPS J       Date:  2017-11-27       Impact factor: 4.009

2.  High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Kathi Hall; C Michael Stein
Journal:  J Clin Psychiatry       Date:  2017-02       Impact factor: 4.384

3.  Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.

Authors:  Meng Wang; Barbara Szepietowska; Bronislava Polonsky; Scott McNitt; Arthur J Moss; Wojciech Zareba; David S Auerbach
Journal:  Am J Cardiol       Date:  2017-11-13       Impact factor: 2.778

4.  Pharmacological Management of Anxiety Disorders in the Elderly.

Authors:  Elizabeth A Crocco; Sindy Jaramillo; Caroline Cruz-Ortiz; Katherine Camfield
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.